RASSF1 and cancer: RARβ2 was observed hypermethylated with cancer‐adjacent tissues (32%) relative to unaffected breast (9%). Promoter methylation of RASSF1A and APC occurred more frequently in breast tissues from unaffected women at high risk for breast cancer than in tissues from women at low/intermediate risk of breast cancer